A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study
Condition(s):Diabetic Kidney DiseaseLast Updated:September 26, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Diabetic Kidney DiseaseLast Updated:September 26, 2023Terminated
Condition(s):Chronic Kidney DiseaseLast Updated:December 2, 2014Unknown status
Condition(s):Chronic Kidney DiseasesLast Updated:August 15, 2023Completed
Condition(s):Kidney DiseasesLast Updated:July 26, 2022Not yet recruiting
Condition(s):Diabetic Kidney DiseaseLast Updated:January 4, 2017Unknown status
Condition(s):Chronic Kidney DiseasesLast Updated:December 22, 2023Completed
Condition(s):Chronic Kidney DiseasesLast Updated:August 23, 2022Recruiting
Condition(s):End-Stage Kidney DiseaseLast Updated:June 7, 2022Recruiting
Condition(s):Diabetic Kidney DiseaseLast Updated:February 16, 2022Completed
Condition(s):Chronic Kidney Diseases; Chronic Kidney Disease 5DLast Updated:February 15, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.